CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody - Phase 3 | RHHBY Pipeline | CatalystAlert